000 01433 a2200397 4500
005 20250511200426.0
264 0 _c19910808
008 199108s 0 0 eng d
022 _a0014-2999
024 7 _a10.1016/0014-2999(91)90134-c
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMonaghan, D T
245 0 0 _aQuinolinate differentiates between forebrain and cerebellar NMDA receptors.
_h[electronic resource]
260 _bEuropean journal of pharmacology
_cFeb 1991
300 _a123-5 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAutoradiography
650 0 4 _aBinding, Competitive
_xdrug effects
650 0 4 _aBrain Chemistry
_xdrug effects
650 0 4 _aCerebellum
_xdrug effects
650 0 4 _aGlutamates
_xmetabolism
650 0 4 _aGlutamic Acid
650 0 4 _aIbotenic Acid
_xpharmacology
650 0 4 _aIn Vitro Techniques
650 0 4 _aKinetics
650 0 4 _aN-Methylaspartate
_xpharmacology
650 0 4 _aQuinolinic Acid
650 0 4 _aQuinolinic Acids
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aReceptors, N-Methyl-D-Aspartate
_xdrug effects
700 1 _aBeaton, J A
773 0 _tEuropean journal of pharmacology
_gvol. 194
_gno. 1
_gp. 123-5
856 4 0 _uhttps://doi.org/10.1016/0014-2999(91)90134-c
_zAvailable from publisher's website
999 _c1682784
_d1682784